From Name:
From Email:
To Name:
To Email:

Optional Message:


MitraClip Redux: Mortality Key in COAPT

from MedPage Today

Safety and efficacy were a win-win for the MitraClip device in the COAPT trial of moderate-to-severe, symptomatic mitral regurgitation patients with heart failure who had exhausted pharmaceutical options. Samir Kapadia, MD, an interventional cardiologist in the Cleveland Clinic Department of Cardiovascular Medicine, discusses the significance of the findings and how he sees the path to routine practice. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063